期刊文献+

慢性移植物抗宿主病患者B细胞活化因子变化的研究

Change of B-cell activating factor in patients with chronic graft-versus-host disease
下载PDF
导出
摘要 目的探讨B细胞活化因子在异基因造血干细胞移植(allo-HSCT)后慢性移植物抗宿主病(cGVHD)发病机理中的作用。方法观察25例allo-HSCT患者cGVHD的发病情况,cGVHD的诊断主要依据临床表现,部分病例取得病理学依据。移植后定期采集25例患者的外周血,采用流式细胞仪检测B细胞活化因子比例。结果cGVHD阳性组的B细胞活化因子比例明显高于cGVHD阴性组(P<0.01)。结论B细胞活化因子比例在cGVHD发生时明显升高,移植后动态监测B细胞活化因子比例的变化有助于cGVHD的诊治。 Objective To study the role of B-cell activating factor in the pathogenesis of chronic graft-versus-host disease(cGVHD) after allogeneic hematopoietic stem cell transplantation(HSCT).Methods Occurrence of cGVHD was observed in 25 patients after allogeneic HSCT.cGVHD was clinically diagnosed and histologically confirmed in some patients by biopsy.Peripheral blood was collected from the 25 patients after allogeneic HSCT.B-cell activating factor levels were measured by flow cytometry.Results The ratio of B-cellactivating factor.
出处 《军医进修学院学报》 CAS 2009年第6期769-771,共3页 Academic Journal of Pla Postgraduate Medical School
基金 国家自然科学基金资助项目(30572108)~~
关键词 移植物抗宿主病 造血干细胞移植 B细胞活化因子 graft vs host disease hematopoietic stem cell transplantation B-cell activating factor
  • 相关文献

参考文献11

  • 1Remberger M, Beelen DW, Fauser A, et al. Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors [J] . Blood, 2005, 105 : 548-551.
  • 2Fraser C J, Bhatia S, Ness K, et al. Impact of chronic graft- versus-host disease on the health status of hematopoietie eell transplantation survivors : a report from the Bone Marrow Transplant Survivor Study [ J ] . Blood, 2006, 108 : 2867-2873.
  • 3Filipovich AH, Weisdorf D, Pavletic S, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft versus host disease : Ⅰ. Diagnosis and staging working group report [ J ] . Biol Blood Marrow Transplant, 2005, 11 (12) : 945-956.
  • 4Zhang C, Todorov I, Zhang Z, et al. Donor CD4^+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations [J]. Blood, 2006, 107 : 2993- 3001.
  • 5She K, Gilman AL, Aslanian S, et al. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease [ J ] . Biol Blood Marrow Transplant, 2007, 13 : 386-397.
  • 6Cutler C, Miklos D, Kim HT, et al. Rituximab for steroidrefractory chronic graft-versus-host disease [ J ] . Blood, 2006, 108 : 756-762.
  • 7Per JO, Daridon C, Devauchelle V, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases [J] . Ann N Y Acad Sci, 2005, 1050 : 34-39.
  • 8Kalled SL, Ambrose C, Hsu YM. The biochemistry and biology of BAFF, APRIL and their receptors [ J ] . Curr Dir Autoimmun, 2005, 8 : 206-242.
  • 9Gamal B, Gwenoline B, Eric A, et al. BAFF enhances chemotaxis of primary human B cells : a particular synergy between BAFF and CXCL13 on memory B cells [ J ] . Blood, 2008, 111 : 2744-2754.
  • 10Sarantopoulos S, Stevenson KE, Kim HT, et al. High levels of B-cell activating factor in patients with active chronic graftversus-host disease [ J ] . Clin Cancer Res, 2007, 13 : 6107- 6114.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部